USANA Health Sciences (NYSE:USNA) issued its quarterly earnings data on Tuesday. The company reported $1.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.87 by $0.22, RTT News reports. The company had revenue of $260.60 million for the quarter, compared to analyst estimates of $256.22 million. USANA Health Sciences had a net margin of 9.68% and a return on equity of 27.22%. The company’s revenue was down 12.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.24 earnings per share. USANA Health Sciences updated its FY 2019 guidance to $3.90-4.05 EPS and its FY19 guidance to $3.90-4.05 EPS.
NYSE:USNA traded up $2.72 during mid-day trading on Tuesday, reaching $72.62. 151,573 shares of the company’s stock were exchanged, compared to its average volume of 246,984. USANA Health Sciences has a one year low of $58.30 and a one year high of $125.61. The firm has a market capitalization of $1.55 billion, a PE ratio of 14.07 and a beta of 0.39. The business’s fifty day simple moving average is $69.55 and its two-hundred day simple moving average is $72.32.
In related news, Director Robert Auciaux sold 4,018 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $71.87, for a total transaction of $288,773.66. The transaction was disclosed in a document filed with the SEC, which is available through this link. 42.50% of the stock is currently owned by company insiders.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
See Also: Why is the price-sales ratio important?
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.